For: | Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: An updated review. World J Gastrointest Pharmacol Ther 2016; 7(4): 477-489 [PMID: 27867681 DOI: 10.4292/wjgpt.v7.i4.477] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i4/477.htm |
Number | Citing Articles |
1 |
Jie Yin, Jingyin Dong, Wei Gao, Yina Wang. A case report of remarkable response to association of radiofrequency ablation with subsequent Atezolizumab in stage IV nonsmall cell lung cancer. Medicine 2018; 97(44): e13112 doi: 10.1097/MD.0000000000013112
|
2 |
Wenjuan Liu, Chunlin Xu, Qingyang Meng, Peng Kang. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101527 doi: 10.1016/j.clinre.2020.08.005
|
3 |
Liang Pan, Chong Sun, Kang Zhou, Matteo Figini, Bin Wang, Junjie Shangguan, Su Hu, Jia Yang, Wei Xing, Jian Wang, Yury Velichko, Vahid Yaghmai, Zhuoli Zhang. Transcatheter Intraarterial Perfusion MRI Approaches to Differentiate Reversibly Electroporated Penumbra From Irreversibly Electroporated Zones in Rabbit Liver. Academic Radiology 2020; 27(12): 1727 doi: 10.1016/j.acra.2020.01.008
|
4 |
Wencheng Tan, Qiwen Deng, Shiyong Lin, Yuhong Wang, Guoliang Xu. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. International Journal of Hyperthermia 2019; 36(1): 263 doi: 10.1080/02656736.2018.1562571
|
5 |
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
|
6 |
Ya-Wen Zou, Zhi-Gang Ren, Ying Sun, Zhen-Guo Liu, Xiao-Bo Hu, Hai-Yu Wang, Zu-Jiang Yu. The latest research progress on minimally invasive treatments for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 54 doi: 10.1016/j.hbpd.2022.08.004
|
7 |
Zhen Liu, Xiaofei Wang, Lei Xing, Yan Pan, Shengchuan Huang. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(10): 621 doi: 10.1089/cbr.2019.2845
|
8 |
Qiwei Zhang, Yunbing Wang, Junyong Zhang, Wenfeng Zhang, Jianping Gong, Rong Ma. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211060180
|
9 |
Umer Salati, Aisling Barry, Frank Y Chou, Roy Ma, David M Liu. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma. Future Oncology 2017; 13(16): 1437 doi: 10.2217/fon-2017-0061
|
10 |
Sahar Semaan, Jasnit Makkar, Sara Lewis, Manjil Chatterji, Edward Kim, Bachir Taouli. Imaging of Hepatocellular Carcinoma Response After90Y Radioembolization. American Journal of Roentgenology 2017; 209(5): W263 doi: 10.2214/AJR.17.17993
|
11 |
Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu. Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer. Nanoscale 2018; 10(33): 15677 doi: 10.1039/C8NR03927E
|
12 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
13 |
Xuefeng Kan, Yanqiao Ren, Xin Li, Xiangchuang Kong, Yanrong Zhang, Qian Li, Fang Liu, Yajing Zhang, Chuansheng Zheng. Value of 18F-FDG PET/MR Imaging in the Early Evaluation of Treatment Response following Radiofrequency Ablation of Liver Cancer in a Rabbit Model. Journal of Vascular and Interventional Radiology 2022; 33(4): 452 doi: 10.1016/j.jvir.2021.09.016
|
14 |
Yenisetti Rajendra Prasad, J. Anakha, Abhay H. Pande. Treating liver cancer through arginine depletion. Drug Discovery Today 2024; 29(4): 103940 doi: 10.1016/j.drudis.2024.103940
|
15 |
Shelley Yap, Ean H. Ooi, Ji J. Foo, Ean T. Ooi. Bipolar radiofrequency ablation treatment of liver cancer employing monopolar needles: A comprehensive investigation on the efficacy of time-based switching. Computers in Biology and Medicine 2021; 131: 104273 doi: 10.1016/j.compbiomed.2021.104273
|
16 |
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de la Tijera, D. Huitzil-Melendez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamiento. Revista de Gastroenterología de México 2022; 87(3): 362 doi: 10.1016/j.rgmx.2022.01.006
|
17 |
Guoqun Jia, Fengjuan Li, Ruiying Tong, Ying Liu, Mengna Zuo, Libing Ma, Xiang Ji. c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation. Medical Oncology 2020; 37(12) doi: 10.1007/s12032-020-01444-z
|
18 |
Tariq M Shaqran, Jaber Alharbi, Shahad K Al-Hunbusi, Rayan A Alharbi, Mayadah Alawaji, Aman M Diqarshawi, Rakan J Almokhlef, Alanoud A Alfaqih, Ruyuf A Alhumaidi, Hussam A Alzahrani, Ibtesam M Alzyad, Zainab S Alwusaybie, Nashmi M Alotaibi, Nawaf Jamaan Alzahrani. Comparison of Radiofrequency Ablation and Microwave Ablation for the Management of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus 2024; doi: 10.7759/cureus.67938
|
19 |
Jenna L. Mueller, Robert Morhard, Michael DeSoto, Erika Chelales, Jeffrey Yang, Corrine Nief, Brian Crouch, Jeffrey Everitt, Rebecca Previs, David Katz, Nimmi Ramanujam. Optimizing ethyl cellulose-ethanol delivery towards enabling ablation of cervical dysplasia. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96223-9
|
20 |
Wan Yee Lau, Stephanie Hiu Yan Lau. The current role of radiofrequency ablation in the treatment of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2017; 16(2): 122 doi: 10.1016/S1499-3872(16)60182-0
|
21 |
Junjie Liu, Jinming Zhao, H. A. O. Gu, Zhiqiang Zhu. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis. Minimally Invasive Therapy & Allied Technologies 2022; 31(3): 332 doi: 10.1080/13645706.2020.1839775
|
22 |
William T.N. Culp. Withrow and MacEwen's Small Animal Clinical Oncology. 2019; : 174 doi: 10.1016/B978-0-323-59496-7.00011-6
|
23 |
Annabel Boyer, Marc-Antoine Jegonday, Antoine Lanot, Maxence Ficheux, Thierry Lobbedez, Clémence Bechade. Percutaneous Ablation for Hepatocellular Carcinoma and Peritoneal Dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 2017; 37(6): 656 doi: 10.3747/pdi.2017.00073
|
24 |
Mariana I. Chavez, Christopher Coon, T. Clark Gamblin. Colorectal Cancer Liver Metastases. 2020; : 487 doi: 10.1007/978-3-030-25486-5_36
|
25 |
Corrine Nief, Robert Morhard, Erika Chelales, Daniel Adrianzen Alvarez, Ioanna Bourla BS, Christopher T. Lam, Alan A. Sag, Brian T. Crouch, Jenna L. Mueller, David Katz, Mark W. Dewhirst, Jeffrey I. Everitt, Nirmala Ramanujam, Feng Zhang. Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model. PLOS ONE 2021; 16(1): e0234535 doi: 10.1371/journal.pone.0234535
|
26 |
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
|
27 |
Xuefeng Kan, Feng Zhang, Guanhui Zhou, Hongxiu Ji, Wayne Monsky, Christopher Ingraham, Chuansheng Zheng, Xiaoming Yang. Interventional real-time optical imaging guidance for complete tumor ablation. Proceedings of the National Academy of Sciences 2021; 118(41) doi: 10.1073/pnas.2113028118
|
28 |
Jun Sik Yoon, Gyeonghwa Kim, Yu Rim Lee, Soo Young Park, Won Young Tak, Young-Oh Kweon, Jung Gil Park, Hye Won Lee, Young Seok Han, Heon Tak Ha, Jae Min Chun, Se Young Jang, Keun Hur. Clinical Significance of Microrna-21 Expression in Disease Progression of Patients With Hepatocellular Carcinoma. Biomarkers in Medicine 2018; 12(10): 1105 doi: 10.2217/bmm-2018-0096
|
29 |
Naïk Vietti Violi, Rafael Duran, Boris Guiu, Jean-Pierre Cercueil, Christophe Aubé, Antonia Digklia, Isabelle Pache, Pierre Deltenre, Jean-François Knebel, Alban Denys. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. The Lancet Gastroenterology & Hepatology 2018; 3(5): 317 doi: 10.1016/S2468-1253(18)30029-3
|
30 |
Li Wang, Xiaoyue Wang, Xuejun Wang. The effectiveness of enteral nutrition for patients with primary liver cancer. Medicine 2021; 100(3): e23973 doi: 10.1097/MD.0000000000023973
|
31 |
Atsuo Takigawa, Ryotaro Sakamori, Yuki Tahata, Teppei Yoshioka, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Takayuki Yakushijin, Kazuyoshi Ohkawa, Naoki Hiramatsu, Eiji Mita, Hideki Hagiwara, Toshifmi Ito, Yasuharu Imai, Tomohide Tatsumi, Tetsuo Takehara. Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller. Digestive Diseases and Sciences 2022; 67(12): 5704 doi: 10.1007/s10620-022-07455-2
|
32 |
Xuan-Yu Gu, Jin-Long Huo, Zhi-Yong Yu, Ji-Chang Jiang, Ya-Xuan Xu, Li-Jin Zhao. Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects. Oncologie 2024; 26(1): 9 doi: 10.1515/oncologie-2023-0412
|
33 |
Jason Liu, Colton Ladbury, Yi-Jen Chen. Interventional Oncology. 2023; : 1 doi: 10.1007/978-3-030-51192-0_85-1
|
34 |
Wen-Chang Yu, Kong-Zhi Zhang, Shi-Guang Chen, Wei-Fu Liu. Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma. Medicine 2018; 97(3): e9704 doi: 10.1097/MD.0000000000009704
|
35 |
Yinglin Long, Ronghua Yan, Kai Li, Liping Luo, Qingjing Zeng, Lei Tan, Man Zhang, Rongqin Zheng, Erjiao Xu. Radiofrequency ablation of liver cancers adjacent to the gallbladder without gallbladder isolation under contrast-enhanced ultrasound monitoring: a preliminary study. International Journal of Hyperthermia 2019; 36(1): 139 doi: 10.1080/02656736.2018.1539776
|
36 |
Kate Krause, Kenneth K. Tanabe. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Annals of Surgical Oncology 2020; 27(9): 3330 doi: 10.1245/s10434-020-08580-w
|
37 |
Teresa Marzia Rogger, Andrea Michielan, Sandro Sferrazza, Cecilia Pravadelli, Luisa Moser, Flora Agugiaro, Giovanni Vettori, Sonia Seligmann, Elettra Merola, Marcello Maida, Francesco Antonio Ciarleglio, Alberto Brolese, Giovanni de Pretis. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature. World Journal of Gastroenterology 2020; 26(35): 5375-5386 doi: 10.3748/wjg.v26.i35.5375
|
38 |
Hidenori Mitani, Akira Naito, Keigo Chosa, Hisayuki Kodama, Masumi Sumida, Takashi Moriya, Kazuo Awai. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic dome. Minimally Invasive Therapy & Allied Technologies 2022; 31(6): 894 doi: 10.1080/13645706.2021.1995436
|
39 |
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World Journal of Hepatology 2020; 12(10): 738-753 doi: 10.4254/wjh.v12.i10.738
|
40 |
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, Hui Zheng, Jeffrey Forris Beecham Chick, Karim Valji, Chuansheng Zheng, Xiaoming Yang. Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection. Cancer Research 2021; 81(17): 4594 doi: 10.1158/0008-5472.CAN-21-1040
|
41 |
Jens Ziegle, Chloé Audigier, Johannes Krug, Ghazanfar Ali, Younsu Kim, Emad M. Boctor, Michael Friebe. RF-ablation pattern shaping employing switching channels of dual bipolar needle electrodes: ex vivo results. International Journal of Computer Assisted Radiology and Surgery 2018; 13(6): 905 doi: 10.1007/s11548-018-1769-8
|
42 |
Qian Yu, Chenyu Liu, Rakesh Navuluri, Osman Ahmed. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Abdominal Radiology 2021; 46(9): 4467 doi: 10.1007/s00261-021-03080-1
|
43 |
Ali Morshid, Khaled M. Elsayes, Ahmed M. Khalaf, Mohab M. Elmohr, Justin Yu, Ahmed O. Kaseb, Manal Hassan, Armeen Mahvash, Zhihui Wang, John D. Hazle, David Fuentes. A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence 2019; 1(5): e180021 doi: 10.1148/ryai.2019180021
|
44 |
Ahmed W. Moawad, David Fuentes, Ahmed M. Khalaf, Katherine J. Blair, Janio Szklaruk, Aliya Qayyum, John D. Hazle, Khaled M. Elsayes. Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00572
|
45 |
Zhi-Shan Du, Ying-Song Wang, Jing-Ming Xie, Tao Li, Zhi-Yue Shi, Qiu-An Lu, Ying Zhang, Zhi Zhao, Ni Bi, Zhi-Bo Song, Ting-Biao Zhu. Feasibility of microwave ablation of the vertebral growth plate for spine growth regulation: a preliminary study. International Journal of Hyperthermia 2021; 38(1): 1233 doi: 10.1080/02656736.2021.1964619
|
46 |
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de la Tijera, D. Huitzil-Melendez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment. Revista de Gastroenterología de México (English Edition) 2022; 87(3): 362 doi: 10.1016/j.rgmxen.2022.01.004
|
47 |
He Ren, Chao An, Ping Liang, Jie Yu, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Linan Dong, Dongrui Li. Ultrasound-guided percutaneous microwave ablation assisted by athree-dimensional visualization treatment platform combined with transcatheter arterial chemoembolization for a single large hepatocellular carcinoma 5 cm or larger: a preliminary clinical application. International Journal of Hyperthermia 2019; 36(1): 44 doi: 10.1080/02656736.2018.1530459
|
48 |
Chen-Hua Ma, Jeffrey Yang, Jenna L. Mueller, Huang-Chiao Huang. Intratumoral Photosensitizer Delivery and Photodynamic Therapy. Nano LIFE 2021; 11(02): 2130003 doi: 10.1142/S179398442130003X
|
49 |
Zhentian Xu, Haiyang Xie, Lin Zhou, Xinhua Chen, Shusen Zheng. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/8619096
|
50 |
Christiaan M. C. Serbanescu-Kele Apor de Zalán, Simeon J. S. Ruiter, Aad P. van den Berg, Jan Pieter Pennings, Koert P. de Jong. Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation. European Radiology 2022; 32(6): 4168 doi: 10.1007/s00330-021-08515-3
|
51 |
Rui Zhang, Min Ma, Gang Dong, Rong‐Rong Yao, Jing‐Huan Li, Qiong‐Dan Zheng, Yin‐Ying Dong, Hui Ma, Dong‐Mei Gao, Jie‐Feng Cui, Zheng‐Gang Ren, Rong‐Xin Chen. Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment. Cancer Science 2017; 108(9): 1778 doi: 10.1111/cas.13322
|
52 |
Antonio Facciorusso, Andrea Chierici, Ivan Cincione, Rodolfo Sacco, Daryl Ramai, Babu P Mohan, Saurabh Chandan, Andrew Ofosu, Christian Cotsoglou. Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis. Expert Review of Anticancer Therapy 2021; 21(6): 681 doi: 10.1080/14737140.2021.1891887
|
53 |
Suayib Yalcin, Sahin Lacin, Ahmed Kaseb, Bora Peynircioğlu, Murat Cantasdemir, Barbaros Çil, Pervin Hurmuz, Ahmet Doğrul, Murat Bozkurt, Hüseyin Abali, Okan Akhan, Halis Şimşek, Berksoy Sahin, Faruk Aykan, İdris Yücel, Gürkan Tellioğlu, Fatih Selçukbiricik, Philip Philip. A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements. Journal of Hepatocellular Carcinoma 2024; : 953 doi: 10.2147/JHC.S449540
|
54 |
Antonio Facciorusso, Mohamed A. Abd El Aziz, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Sara Pusceddu, Luca Giacomelli, Antonio Ambrosi, Rodolfo Sacco. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Cancers 2020; 12(12): 3796 doi: 10.3390/cancers12123796
|
55 |
Zhigang Wei, Xin Ye, Xia Yang, Aimin Zheng, Guanghui Huang, Shenming Dong, Wenhong Li, Jiao Wang, Xiaoying Han, Min Meng, Yang Ni. The efficacy and safety of microwave ablation in patients with retroperitoneal metastases. International Journal of Hyperthermia 2018; 34(7): 1053 doi: 10.1080/02656736.2017.1390788
|
56 |
Sophia K. McKinley, Akhil Chawla, Cristina R. Ferrone. Inoperable Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019; 28(4): 745 doi: 10.1016/j.soc.2019.06.009
|
57 |
Noriyuki Miyamoto, Motoma Kanaya, Takaaki Fujii, Hirotaka Kato, Kyohei Kudo, Naoya Kinota. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy. Japanese Journal of Radiology 2021; 39(4): 376 doi: 10.1007/s11604-020-01064-7
|
58 |
Amer Khan, Marcin Mostowy, Michael Owusu, Mercy Mutambanengwe, Samson Habimana, Somoskoi Bence, Antonio Facciorusso. Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 829 doi: 10.1080/17474124.2021.1869939
|
59 |
J. Roller, V. Zimmer, A. Bücker, M. Glanemann, R.M. Eisele. Conservative treatment of gastric perforation after microwave ablation of a hepatocellular carcinoma. Medicine 2022; 101(22): e29195 doi: 10.1097/MD.0000000000029195
|
60 |
Zhefeng Huang, Anthony L. Gunderman, Samuel E. Wilcox, Saikat Sengupta, Jay Shah, Aiming Lu, David Woodrum, Yue Chen. Body-Mounted MR-Conditional Robot for Minimally Invasive Liver Intervention. Annals of Biomedical Engineering 2024; 52(8): 2065 doi: 10.1007/s10439-024-03503-2
|
61 |
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indications. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
|
62 |
Adam Hatzidakis, Lukas Müller, Miltiadis Krokidis, Roman Kloeckner. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations. Cancers 2022; 14(10): 2469 doi: 10.3390/cancers14102469
|
63 |
Dagmar Kollmann, Nazia Selzner, Markus Selzner. Bridging to liver transplantation in HCC patients. Langenbeck's Archives of Surgery 2017; 402(6): 863 doi: 10.1007/s00423-017-1609-2
|
64 |
Minjiang Chen, Feng Zhang, Jingjing Song, Qiaoyou Weng, Peicheng Li, Qiang Li, Kun Qian, Hongxiu Ji, Sean Pietrini, Jiansong Ji, Xiaoming Yang. Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.593996
|
65 |
Hui Zheng, Feng Zhang, Wayne Monsky, Hongxiu Ji, Weizhu Yang, Xiaoming Yang. Interventional Optical Imaging-Monitored Synergistic Effect of Radio-Frequency Hyperthermia and Oncolytic Immunotherapy. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.821838
|
66 |
Allen Mo, Christian Velten, Julie M. Jiang, Justin Tang, Nitin Ohri, Shalom Kalnicki, Parsa Mirhaji, Kei Nemoto, Boudewijn Aasman, Madhur Garg, Chandan Guha, N. Patrik Brodin, Rafi Kabarriti. Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence–Based Decision-Making Tool. JCO Clinical Cancer Informatics 2022; (6) doi: 10.1200/CCI.22.00024
|
67 |
Rui Zhang, Min Ma, Xia-Hui Lin, Hua-Hua Liu, Jie Chen, Jun Chen, Dong-Mei Gao, Jie-Feng Cui, Zheng-Gang Ren, Rong-Xin Chen. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4820-9
|
68 |
Riccardo Memeo, Patrick Pessaux, Nicola Silvestris, Oronzo Brunetti, Antonio Giovanni Solimando, Andrea Casadei Gardini. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 689 doi: 10.1007/978-3-030-56051-5_42
|
69 |
Abigail Mills, David Thayer, Christopher Noda, Amber Salter, Yu Tao, Minzhi Xing, Robert Martin, Raja Ramaswamy, Olaguoke Akinwande. Thermal Ablation Versus Surgical Resection for Localized Hepatocellular Carcinoma: A Population Study Using the SEER Database. Future Oncology 2018; 14(7): 631 doi: 10.2217/fon-2017-0447
|
70 |
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
|
71 |
Zahra Farzaneh, Maryam Farzaneh. Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2022; 18(4): 230 doi: 10.2174/1573394718666220519115626
|
72 |
A.M. Khalaf, D. Fuentes, A. Morshid, A.O. Kaseb, M. Hassan, J.D. Hazle, K.M. Elsayes. Hepatocellular carcinoma response to transcatheter arterial chemoembolisation using automatically generated pre-therapeutic tumour volumes by a random forest-based segmentation protocol. Clinical Radiology 2019; 74(12): 974.e13 doi: 10.1016/j.crad.2019.07.023
|
73 |
Tong Kang, Jiamin Chen, Weijun Wan, Jinshu Pang, Rong Wen, Xiumei Bai, Lipeng Li, Yunjing Pan, Yun He, Hong Yang. Overexpression of PLK1 Molecule Following Incomplete Thermal Ablation Promotes the Proliferation and Invasion of Residual Hepatocellular Carcinoma. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01181-y
|
74 |
Yan-Hua Zhang, Bo Su, Pei Sun, Ru-Meng Li, Xiao-Chun Peng, Jun Cai. Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma. World Journal of Clinical Cases 2020; 8(19): 4380-4387 doi: 10.12998/wjcc.v8.i19.4380
|
75 |
Lyudmila Levchenko, Yelyzaveta Kozachuk, Sergey Zemskov. ЗАСТОСУВАННЯ ПЕРКУТАННОЇ ХІМІЧНОЇ АБЛЯЦІЇ В ЛІКУВАННІ ПАЦІЄНТІВ З ГЕПАТОЦЕЛЮЛЯРНОЮ КАРЦИНОМОЮ. The Ukrainian Scientific Medical Youth Journal 2020; 116(2): 33 doi: 10.32345/USMYJ.2(116).2020.33-43
|
76 |
Hai-Yan Wang, Xiong-Wei Cui, Yong-Hong Zhang, Yu Chen, Ning-Ning Lu, Shou-Peng Sheng, Wen-Feng Gao, Xiao-Zheng Yang, Zhong-Ping Duan. Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1048049
|
77 |
Joan M. C. Bull. A review of immune therapy in cancer and a question: can thermal therapy increase tumor response?. International Journal of Hyperthermia 2018; 34(6): 840 doi: 10.1080/02656736.2017.1387938
|
78 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
79 |
Jie Han, Yu-chen Fan, Kai Wang. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma. Medicine 2020; 99(43): e22703 doi: 10.1097/MD.0000000000022703
|
80 |
Antonio Giorgio, Pietro Gatti, Luca Montesarchio, Maria Gabriella Merola, Ferdinando Amendola, Andrea Calvanese, Gaetano Iaquinto, Massimiliano Fontana, Emanuela Ciracì, Stefano Semeraro, Bruno Santoro, Carmine Coppola, Paolo Matteucci, Valentina Giorgio. Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study. Journal of Clinical and Translational Hepatology 2018; 6(x): 1 doi: 10.14218/JCTH.2018.00013
|
81 |
Jian-Ying Zeng, Xiang-Hao Piao, Zhong-Yuan Zou, Qing-Feng Yang, Zi-Lin Qin, Ji-Bing Chen, Liang Zhou, Li-Zhi Niu, Jian-Guo Liu. Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis. Oncotarget 2018; 9(7): 7557 doi: 10.18632/oncotarget.24029
|
82 |
L. I. Moskvicheva, D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, M. V. Zabelin. Modern methods of ablation of malignant tumors of the liver. Research'n Practical Medicine Journal 2018; 5(4): 58 doi: 10.17709/2409-2231-2018-5-4-6
|
83 |
Huimei Zhang, Na Chang, Tiantian Han, Shaodi Ma, Guangbo Qu, Haixia Liu, Chenyu Sun, Ce Cheng, Qin Zhou, Yehuan Sun. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncology 2021; 17(30): 4027 doi: 10.2217/fon-2021-0263
|
84 |
Philip Voglreiter, Panchatcharam Mariappan, Mika Pollari, Ronan Flanagan, Roberto Blanco Sequeiros, Rupert Horst Portugaller, Jurgen Fütterer, Dieter Schmalstieg, Marina Kolesnik, Michael Moche. RFA Guardian: Comprehensive Simulation of Radiofrequency Ablation Treatment of Liver Tumors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18899-2
|
85 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
86 |
Riccardo Inchingolo, Alessandro Posa, Martin Mariappan, Stavros Spiliopoulos. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World Journal of Gastroenterology 2019; 25(32): 4614-4628 doi: 10.3748/wjg.v25.i32.4614
|
87 |
Krongthip Sripunjan, Pattharaporn Sombood, Phongtara Vichitvejpaisal, Somchai Amornyotin. Ventilatory Effect of Midazolam in Propofol Deep Sedation for Hepatic Tumor Patients Undergoing Percutaneous Radiofrequency Ablation Procedure. Gastroenterology Insights 2021; 12(1): 89 doi: 10.3390/gastroent12010009
|
88 |
Andri Sanityoso Sulaiman, Rino Alvani Gani, Irsan Hasan, Cosmas Rinaldi A. Lesmana, Juferdy Kurniawan, Chyntia Olivia Maurine Jasirwan, Kemal Fariz Kalista, Saut Horas Hotaguan Nababan, Gita Aprilicia, Laurentius A. Lesmana. Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia. Journal of Gastrointestinal Cancer 2022; 53(3): 632 doi: 10.1007/s12029-021-00676-0
|
89 |
Yujia You, Yinglin Long, Ronghua Yan, Liping Luo, Man Zhang, Lu Li, Qingjing Zeng, Kai Li, Rongqin Zheng, Erjiao Xu. Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.570312
|
90 |
|